Corcept Therapeutics, Inc. (CORT)
83.16
+0.18
(+0.22%)
USD |
NASDAQ |
Dec 09, 16:00
83.16
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 8.748B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 168.99B |
| Gilead Sciences, Inc. | 148.08B |
| LeMaitre Vascular, Inc. | 1.880B |
| United Therapeutics Corp. | 20.52B |
| Vertex Pharmaceuticals, Inc. | 110.83B |
Market Cap Related Metrics
| PE Ratio | 95.02 |
| PS Ratio | 13.41 |
| Price to Book Value | 13.84 |
| Price to Free Cash Flow | 61.16 |
| Price | 83.16 |
| Earnings Yield | 1.05% |
| Operating PE Ratio | 151.63 |
| Normalized PE Ratio | 95.02 |